SEATTLE, WA–(Marketwire -06/13/12)- Integrated Diagnostics (InDi), an emerging leader in molecular diagnostics, today announced that the company has launched a new operating division, InDi Imaging, that is creating a new generation of PET imaging probes using the company’s innovative protein catalyzed capture (PCC) agent technology. PCCs, initially developed for in vitro molecular diagnostics, will be employed as rationally designed, in vivo diagnostic imaging probes that mimic the properties of antibodies and biologics in PET molecular imaging, with the benefit of being chemically stable, synthetic small-molecules Continue reading →